Stock Market News

FDA approves Akeso Biopharma's new drug for nasopharyngeal carcinoma treatment

Apr 24, 2025 - 16:28
 0
FDA approves Akeso Biopharma's new drug for nasopharyngeal carcinoma treatment
Read More

Tags:

Previous Article

Ather Energy reduces IPO size to $308.3 million

Next Article

Bristol Myers posts higher-than-expected quarterly revenue on cancer drug sales

Related Posts